Patent Litigation

As the only law firm in the UK to specialise in acting for generic pharmaceutical companies in patent litigation, Roiter Zucker has achieved ground breaking legal results for its clients in this industry sector.

For 25 years, we have chosen to act exclusively for generic companies in patent actions. In doing so, we have challenged patents and defended infringement proceedings in relation to many blockbuster drugs. We have never lost a case. Our team of industry and patent litigation specialists deliver targeted, commercially relevant advice and, with bureaucracy kept to a minimum, do so at a fraction of the cost charged by our competitors without any compromise on service.

We have acted on some of the UK’s most high profile pharma patent actions, including ones relating to:

• Terfenadine
• Cyclosporine
• Nicorandil
• Paclitaxel
• Paroxetine
• Perindopril
• Seretide®
• Symbicort®  
• Augmentin®
• Tibolone

In addition to representing clients in actions before the High Court, Court of Appeal and House of Lords, we also have extensive experience of litigating patents in most EU Member States, and regularly advise on EPO Oppositions.